Institut Català d'oncologia - ICO Badalona

Badalona, Barcelona 08916

0 studies enrolling now · 2 studies all time

What they study most

AML/MDS, CMML, Metastatic Breast Cancer, Refractory Acute Lymphoblastic Leukemia, Relapse, Relapse Leukemia, Relapsed Adult AML

Studies at this site

• Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype — Stopped early
• Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML — Completed